CHARACTERIZATION OF VERY VIRULENT MAREKS-DISEASE VIRUSES ISOLATED IN JAPAN

被引:16
作者
IMAI, K
YUASA, N
IWAKIRI, H
NAKAMURA, K
HIHARA, H
ISHITA, T
INAMOTO, A
OKAMOTO, I
OHTA, K
MAEDA, M
机构
[1] NATL INST ANIM HLTH, TSUKUBA, IBARAKI 305, JAPAN
[2] NATL LIVESTOCK BREEDING CTR, FUKUSHIMA 961, JAPAN
[3] NIHON PHARM, OHTAWARA, TOCHIGI 32401, JAPAN
关键词
D O I
10.1080/03079459208418824
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Pathogenicity of two isolates of Marek's disease virus (MDV), MS1 and MS2, from chickens was examined in two genetically different strains of chickens, MD-susceptible P-2 chickens and less susceptible PDL-1 chickens. The isolates induced an early mortality syndrome unassociated with lymphoproliferative lesions in P-2 chickens. There were no significant differences in pathogenicity between our isolates and the Md/5 strain of very virulent MDV (vvMDV) in both P-2 and PDL-1 chickens. Protective indices of turkey herpes virus (HVT) vaccine against challenge with MS1 or MS2 in P-2 chickens were 54% and 28%, respectively, whereas HVT gave more than 80% protection in PDL-1 chickens. These results indicate that the two isolates could be classified as vvMDV. In contrast, a bivalent vaccine composed of HVT and serotype 2 MDV, and CVI988 vaccine gave good protection against challenge with the isolates in P-2 chickens; however, the best protection was given by the CBI988 vaccine. This is the first report of isolation of vvMDV in Japan.
引用
收藏
页码:119 / 126
页数:8
相关论文
共 21 条
[1]   PROTECTIVE EFFICACY OF MAREKS-DISEASE VIRUS (MDV) CVI-988 CEF65 CLONE-C AGAINST CHALLENGE INFECTION WITH 3 VERY VIRULENT MDV STRAINS [J].
DEBOER, GF ;
GROENENDAL, JE ;
BOERRIGTER, HM ;
KOK, GL ;
POL, JMA .
AVIAN DISEASES, 1986, 30 (02) :276-283
[2]   REDUCED VACCINAL PROTECTION OF TURKEY HERPESVIRUS AGAINST FIELD STRAINS OF MAREKS-DISEASE HERPESVIRUS [J].
EIDSON, CS ;
ELLIS, MN ;
KLEVEN, SH .
POULTRY SCIENCE, 1981, 60 (02) :317-322
[3]   CELL-FREE OR CELL-ASSOCIATED TURKEY HERPESVIRUS VACCINE AGAINST MAREKS-DISEASE IN CHICKENS AS INFLUENCED BY MATERNAL ANTIBODY, VACCINE DOSE, AND TIME OF EXPOSURE TO MAREKS-DISEASE VIRUS [J].
EIDSON, CS ;
PAGE, RK ;
KLEVEN, SH .
AVIAN DISEASES, 1978, 22 (04) :583-597
[4]   STUDIES ON ACUTE MAREKS DISEASE .I. CHARACTERISTICS OF ISOLATE GA IN CHICKENS [J].
EIDSON, CS ;
SCHMITTLE, SC .
AVIAN DISEASES, 1968, 12 (03) :467-+
[5]   PERFORMANCE OF 3 SUCCESSIVE GENERATIONS OF SPECIFIED-PATHOGEN-FREE CHICKENS MAINTAINED AS A CLOSED FLOCK [J].
FURUTA, K ;
OHASHI, H ;
OBANA, J ;
SATO, S .
LABORATORY ANIMALS, 1980, 14 (02) :107-112
[6]  
IMAI K, 1990, JPN J VET SCI, V52, P873
[7]  
IMAI K, 1988, 3RD P INT S MAR DIS, P414
[8]  
LEE LF, 1983, J IMMUNOL, V130, P1003
[9]   ISOLATION OF VERY VIRULENT MAREKS-DISEASE VIRUSES FROM VACCINATED CHICKENS IN AUSTRALIA [J].
MCKIMMBRESCHKIN, JL ;
FARAGHER, JT ;
WITHELL, J ;
FORSYTH, WM .
AUSTRALIAN VETERINARY JOURNAL, 1990, 67 (06) :205-209
[10]   DEPRESSION OF VACCINAL IMMUNITY TO MAREKS-DISEASE BY INFECTION WITH CHICKEN ANEMIA AGENT [J].
OTAKI, Y ;
NUNOYA, T ;
TAJIMA, M ;
KATO, A ;
NOMURA, Y .
AVIAN PATHOLOGY, 1988, 17 (02) :333-&